Sutro Biopharma (STRO) Current Deferred Revenue (2017 - 2026)
Sutro Biopharma's Current Deferred Revenue came in at $6.46 million for Q2 2026, down 46.0% from $11.96 million a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Sutro Biopharma's Current Deferred Revenue was $10.56 million, down 84.9% from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of -6.3% (FY2020 to FY2025).
- Going back by year, Current Deferred Revenue was $69.78 million in FY2024 (+237.7%), $20.67 million in FY2023 (+23.3%), $16.76 million in FY2022 (+204.9%) and $5.5 million in FY2021 (-62.4%).
- The Q2 2026 figure represents the lowest quarterly Current Deferred Revenue since Q1 2022.
- Year-over-year, Current Deferred Revenue increased in three of the last seven quarters, with growth averaging 53.5%.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q2 2024 (growth of 310.1%), and the weakest in Q3 2025 (a decline of 87.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Sutro Biopharma | 265.72 Mn | -412.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.46 Mn |
| Dec 31, 2025 | 10.56 Mn |
| Sep 30, 2025 | 8.98 Mn |
| Jun 30, 2025 | 11.96 Mn |
| Mar 31, 2025 | 68.98 Mn |
| Dec 31, 2024 | 69.78 Mn |
| Sep 30, 2024 | 72.56 Mn |
| Jun 30, 2024 | 73.96 Mn |
| Mar 31, 2024 | 20.50 Mn |
| Dec 31, 2023 | 20.67 Mn |
| Sep 30, 2023 | 23.98 Mn |
| Jun 30, 2023 | 18.04 Mn |
| Mar 31, 2023 | 17.19 Mn |
| Dec 31, 2022 | 16.76 Mn |
| Sep 30, 2022 | 15.92 Mn |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 6.28 Mn |
| Dec 31, 2021 | 5.50 Mn |
| Sep 30, 2021 | 7.80 Mn |
| Jun 30, 2021 | 8.13 Mn |
API Access
Sutro Biopharma Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();